Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Sep 04, 2012 |
enacting clause stricken |
Jan 04, 2012 |
referred to health |
Jan 25, 2011 |
referred to health |
Assembly Bill A3573
2011-2012 Legislative Session
Sponsored By
RIVERA P
Archive: Last Bill Status - Stricken
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
Philip Ramos
Vito Lopez
Naomi Rivera
Carmen E. Arroyo
2011-A3573 (ACTIVE) - Details
- Law Section:
- Public Health Law
- Laws Affected:
- Amd ยงยง272 & 274, Pub Health L
- Versions Introduced in 2009-2010 Legislative Session:
-
A7645
2011-A3573 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 3573 2011-2012 Regular Sessions I N A S S E M B L Y January 25, 2011 ___________ Introduced by M. of A. P. RIVERA, RAMOS, V. LOPEZ, N. RIVERA, ARROYO, J. RIVERA -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to providing that no prior authorization shall be required under the preferred drug program for all medications indicated by the Food and Drug Administration for the treatment of asthma THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 12 of section 272 of the public health law, as added by section 10 of part C of chapter 58 of the laws of 2005, is amended to read as follows: 12. No prior authorization shall be required under the preferred drug program for: (a) atypical anti-psychotics; (b) anti-depressants; (c) anti-retrovirals used in the treatment of HIV/AIDS; [and] (d) anti-re- jection drugs used for the treatment of organ and tissue transplants; (e) any other therapeutic class for the treatment of mental illness or HIV/AIDS, recommended by the committee and approved by the commissioner under this section; AND (F) ALL MEDICATIONS INDICATED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF ASTHMA. S 2. Paragraphs (b) and (c) of subdivision 3 of section 274 of the public health law, as added by section 10 of part C of chapter 58 of the laws of 2005, are amended and a new paragraph (d) is added to read as follows: (b) the potential for, or a history of, overuse, abuse, drug diversion or illegal utilization; [and] (c) the potential for, or a history of, utilization inconsistent with approved indications. Where the commissioner finds that a drug meets at least one of these criteria, in determining whether to make the drug subject to prior authorization under the clinical drug review program, the commissioner shall consider whether similarly effective alternatives EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD00428-01-1
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.